Morphometric and Ki-67 proliferative index-related characteristics of meningiomas and their correlation with demographic, clinical, histopathological, and postoperative features
By
Ragib Pugonja
,
Ragib Pugonja
Department of General Medicine, School of Medicine, University of Zenica,
Zenica, Bosnia and Herzegovina
Department of Anatomy, School of Medicine, University of Zenica,
Zenica, Bosnia and Herzegovina
Aim To investigate the correlations between tumour characteristics, symptoms, intraoperative findings, and outcomes in patient with meningioma. Methods A retrospective study was conducted on 86 surgically treated patients at Department of Neurosurgery of Cantonal Hospital Zenica from 2010 to 2020. Patients with intracranial meningiomas underwent neurological evaluation and MRI scans to analyse tumour characteristics, including volume (TV), peritumoral brain oedema (PTBE) and oedema index (EI). Surgical treatment was performed, followed by postoperative MRI and outcome assessment. Intraoperatively, the tumour’s relationship with cortex, pial membrane, skull bones, and sinuses was evaluated, and the extent of tumour resection was graded. Meningioma samples underwent histopathological analysis to assess the grade and regularity of borders, and Ki-67 labelling index was determined using immunohistochemistry. Results Significant correlations were found between PTBE and Ki67 expression (p<0.001), PTBE and vomiting/nausea (p=0.002), cognitive impairment (p=0.047), venous compression (p=0.001), cortical, pial and dural invasion (p<0.05), and the postoperative presence of oedema (p=0.002). Venous compression, cortical, pial, dural and bone invasion positively correlated with Ki-67 expression (p<0.001). Grade and tumour border positively correlated with Ki-67 expression (p<0.001). Oedema persistence postoperatively showed a positive correlation with Ki-67 expression (p<0.001). Conclusion The study revealed significant correlations between Ki-67 expression and PTBE, with notable associations with clinical symptoms, tumour characteristics, and postoperative oedema presence.
Bečulić H. Hirurgija tumora centralnog nervnog sistema (Central nervous system tumor surgery. 2016.
2.
Bondy M, Ligon BL. Epidemiology and etiology of intracranial meningiomas: a review. Vol. 29, J Neurooncol. 1996. p. 197–205.
3.
Wiemels J, Wrensch M, Claus EB. Epidemiology and etiology of meningioma. Vol. 99, J Neurooncol. 2010. p. 307–14.
4.
Kuratsu J, Kochi M, Ushio Y. Incidence and clinical features of asymptomatic meningiomas. Vol. 92, J Neurosurg. 2000. p. 766–70.
5.
Fotopoulos AD, Alexiou GA, Goussia A, Papadopoulos A, Kyritsis AP, Polyzoidis KS, et al. 99m)Tc-Tetrofosmin brain SPECT in the assessment of meningiomas-correlation with histological grade and proliferation index. Vol. 89, J Neurooncol. 2008. p. 225–30.
6.
Yoshioka H, Hama S, Taniguchi E, Sugiyama K, Arita K, Kurisu K. Peritumoral brain edema associated with meningioma, influence of vascular endothelial growth factor expression and vascular blood supply. Vol. 85, Cancer. 1999. p. 936–44.
7.
Bečulić H, Skomorac R, Jusić A, Alić F, Mašović A, Burazerović E, et al. Correlation of peritumoral brain edema with morphological characteristics and Ki-67 proliferative index in resected intracranial meningiomas. Vol. 58, Acta Clin Croat. 2019. p. 42–9.
8.
Liu N, Song SY, Jiang JB, Wang TJ, Yan CX. The prognostic role of Ki-67/MIB-1 in meningioma: a systematic review with meta-analysis.
9.
Simis A, Aguiar PH, Leite CC, PA S, Rosemberg S, Teixeira MJ. Peritumoral brain edema in benign meningiomas: correlation with clinical, radiologic, and surgical factors and possible role in recurrence. Vol. 70, Surg Neurol. 2008. p. 471–7.
10.
Ide M, Jimbo M, Kubo O, Yamamoto M, Takeyama E, Imanaga H. Peritumoral brain edema and cortical damage by meningioma. Vol. 60. 1994. p. 369–72.
11.
Kim BW, Kim MS, Kim SW, Chang CH, Kim OL. Peritumoral brain edema in meningiomas: correlation of radiologic and pathologic features. Vol. 49, J Korean Neurosurg Soc. 2011. p. 26–30.
12.
Ahmeti H, Caliebe A, Röcken C, Jansen O, Mehdorn MH, Synowitz M. Impact of peritumoral brain edema on pre- and postoperative clinical conditions and on long-term outcomes in patients with intracranial meningiomas. Vol. 28, Eur J Med Res. 2023. p. 40–5.
13.
Imam N, Elghriany AI, Elshanawany AM, Elhakeem AAS. Ki-67 proliferative index and peritumoral brain edema in meningiomas: do they correlate? A clinical study on 56 patients. Vol. 9, Open J Mod Neurosurg. 2019. p. 461–71.
14.
Voß KM, Spille DC, Sauerland C, Suero Molina E, Brokinkel C, Paulus W, et al. The Simpson grading in meningioma surgery: does the tumor location influence the prognostic value? Vol. 133, J Neurooncol. 2017. p. 641–51.
15.
Gawlitza M, Fiedler E, Schob S, Hoffmann KT, Surov A. Peritumoral, or brain edema in meningiomas depends on aquaporin-4 expression and not on tumor grade, tumor volume, cell count Ki-67 Labeling Index. Vol. 19, Mol Imaging Biol. 2017. p. 298–304.
16.
Hess K, Spille DC, Adeli A, Sporns PB, Brokinkel C, Grauer O, et al. Brain invasion and the risk of seizures in patients with meningioma. Vol. 130, J Neurosurg. 2018. p. 789–96.
17.
Ahmeti H, Caliebe A, Röcken C, Jansen O, Mehdorn MH, Synowitz M. Impact of peritumoral brain edema on pre- and postoperative clinical conditions and on long-term outcomes in patients with intracranial meningiomas. Vol. 28, Eur J Med Res. 2023.
18.
Li H, Zhang YS, Zhang GB, Zhang GJ, Wang B, Li D, et al. Treatment protocol, long-term follow-up, and predictors of mortality in 302 cases of atypical meningioma. World Neurosurg. 2019. p. 122 1275-84.
19.
Küçükosmanoğlu İ, Karanis MİE, Ünlü Y. Çöven İ.Evaluation of P57, P53 and Ki-67 expression in meningiomas. Vol. 65, J Korean Neurosurg Soc. 2022. p. 506.
20.
Ogasawara C, Philbrick BD, Adamson DC. Meningioma: a review of epidemiology, pathology, diagnosis, treatment, and future directions. Vol. 9, Biomedicines. 2021.
21.
Yamada S, Kijima N, Nakagawa T, Hirayama R, Kinoshita M, Kagawa N, et al. How much tumor volume is responsible for development of clinical symptoms in patients with convexity, parasagittal and falx meningiomas? Vol. 12, Front Neurol. 2021.
22.
Lobato RD, Alday R, Gómez PA, Rivas JJ, Domínguez J, Cabrera A, et al. Brain oedema in patients with intracranial meningioma. Correlation between clinical, radiological, and histological factors and the presence and intensity of oedema. Vol. 138, Acta Neurochir (Wien. 1996. p. 485–93.
23.
Maiuri F, Gangemi M, Cirillo S, Delehaye L, Gallicchio B, Carandente M, et al. Cerebral edema associated with meningiomas. Vol. 27, Surg Neurol. 1987. p. 64–8.
24.
Bradac GB, Ferszt R, Bender A, Schörner W. Peritumoral edema in meningiomas. A radiological and histological study. Vol. 28, Neuroradiology. 1986. p. 304–12.
25.
Lee KJ, Joo WI, Rha HK, Park HK, Chough JK, Hong YK, et al. Peritumoral brain edema in benign meningiomas: correlation with clinical, radiologic, and surgical factors and possible role in recurrence. Vol. 70, Surg Neurol. 2008. p. 471–7.
26.
Loewenstern J, Aggarwal A, Pain M, Barthélemy E, Costa A, Bederson J, et al. Peritumoral edema relative to meningioma size predicts functional outcomes after resection in older patients. Vol. 16, Oper Neurosurg (Hagerstown. 2019. p. 281–91.
27.
Bommakanti K, Somayajula S, Suvarna A, Purohit AK, Mekala S, Chadalawadi SK, et al. Pre-operative and post-operative cognitive deficits in patients with supratentorial meningiomas. Vol. 143, Clin Neurol Neurosurg. 2016. p. 150–8.
28.
Markovic M, Antunovic V, Milenkovic S, Zivkovic N. Prognostic value of peritumoral edema and angiogenesis in intracranial meningioma surgery. Vol. 18, J BUON. 2013. p. 430–6.
29.
Paek SH, Kim CY, Kim YY, Park IA, Kim MS, Kim DG, et al. Correlation of clinical and biological parameters with peritumoral edema in meningioma. Vol. 60, J Neurooncol. 2002. p. 235–45.
30.
Zeng L, Wang L, Ye F, Chen J, Lei T, Chen J. Clinical characteristics of patients with asymptomatic intracranial meningiomas and results of their surgical management. Vol. 38, Neurosurg Rev. 2015. p. 481–8.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
